Diagnostic and prognostic value of human prion detection in cerebrospinal fluid
暂无分享,去创建一个
B. Caughey | L. Schonberger | C. Tatsuoka | P. Gambetti | B. Appleby | A. Hughson | J. Safar | Shulin Zhang | Han Wang | Janis E. Blevins | Aaron Foutz | Yvonne Cohen | Clive Hamlin | M. Cohen | Wei Chen | Xiaoqin Liu | Sheng Yang | Cameron L Fausett
[1] A. Karch,et al. Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic , 2016, Molecular Neurobiology.
[2] B. Miller,et al. Rapidly Progressive Dementia , 2016, Continuum.
[3] B. Appleby,et al. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease , 2016, Prion.
[4] Ashley M. Lee,et al. Diagnostic Value and Safety of Brain Biopsy in Patients With Cryptogenic Neurological Disease: A Systematic Review and Meta-analysis of 831 Cases. , 2015, Neurosurgery.
[5] A. Karch,et al. Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease , 2015, Neurobiology of Aging.
[6] Wei Chen,et al. Structural Determinants of Phenotypic Diversity and Replication Rate of Human Prions , 2015, PLoS pathogens.
[7] A. Karch,et al. Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease , 2015, Molecular Neurobiology.
[8] J. Neuhaus,et al. Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease , 2015, Neurology. Clinical practice.
[9] J. Haines,et al. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β. , 2015, Brain : a journal of neurology.
[10] P. Nelson,et al. Unlocking the mysteries of TDP-43 , 2015, Neurology.
[11] B. Caughey,et al. Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid , 2015, mBio.
[12] A. Karch,et al. Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases , 2014, Molecular Neurobiology.
[13] Wei Chen,et al. Co-existence of Distinct Prion Types Enables Conformational Evolution of Human PrPSc by Competitive Selection* , 2013, The Journal of Biological Chemistry.
[14] A. Aguzzi,et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years , 2012, Brain : a journal of neurology.
[15] A. Bizzi,et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2012, Neurology.
[16] Mary Andrews,et al. Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease , 2012, Annals of neurology.
[17] Wei Chen,et al. Small Protease Sensitive Oligomers of PrPSc in Distinct Human Prions Determine Conversion Rate of PrPC , 2012, PLoS pathogens.
[18] A. Bizzi,et al. Sporadic human prion diseases: molecular insights and diagnosis , 2012, The Lancet Neurology.
[19] I. Ferrer,et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA , 2012, Acta Neuropathologica.
[20] B. Caughey,et al. New generation QuIC assays for prion seeding activity , 2012, Prion.
[21] B. Caughey,et al. Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. , 2012, The Journal of general virology.
[22] R. Leigh,et al. Treatable neurological disorders misdiagnosed as Creutzfeldt‐Jakob disease , 2011, Annals of neurology.
[23] Wei Chen,et al. Protease-Sensitive Conformers in Broad Spectrum of Distinct PrPSc Structures in Sporadic Creutzfeldt-Jakob Disease Are Indicator of Progression Rate , 2011, PLoS pathogens.
[24] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[25] Steven J Collins,et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.
[26] Brent Race,et al. Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays , 2010, PLoS pathogens.
[27] G. J. Raymond,et al. Mammalian Prions Generated from Bacterially Expressed Prion Protein in the Absence of Any Mammalian Cofactors* , 2010, The Journal of Biological Chemistry.
[28] J. Langeveld,et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. , 2009, Brain : a journal of neurology.
[29] C. Begue,et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.
[30] B. Caughey,et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking , 2008, Nature Methods.
[31] David W. Colby,et al. Prion detection by an amyloid seeding assay , 2007, Proceedings of the National Academy of Sciences.
[32] B. Caughey,et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein , 2007, Nature Methods.
[33] K. Hess,et al. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis , 2007, Journal of Neurology.
[34] J Mackenzie,et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. , 2006, Brain : a journal of neurology.
[35] K. Hess,et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.
[36] S. Prusiner,et al. Diagnosis of human prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Aguzzi,et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. , 2004, Brain : a journal of neurology.
[38] F. Cohen,et al. Synthetic Mammalian Prions , 2004, Science.
[39] Shu G. Chen,et al. Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.
[40] N. Barbaro,et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.
[41] B. Permanne,et al. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.
[42] F. Cohen,et al. Strain‐specified relative conformational stability of the scrapie prion protein , 2001, Protein science : a publication of the Protein Society.
[43] B. Ghetti,et al. Genetic influence on the structural variations of the abnormal prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] P Brown,et al. Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.
[45] F. Cohen,et al. Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.
[46] F. Cohen,et al. Prion Protein Biology , 1998, Cell.
[47] S. Prusiner,et al. Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.
[48] J Q Trojanowski,et al. Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.
[49] R. Marsh,et al. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.
[50] S. Prusiner,et al. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. , 1992, Genes & development.
[51] P. McBride,et al. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.
[52] J. Safar. Molecular Mechanisms Encoding Quantitative and Qualitative Traits of Prion Strains , 2013 .
[53] S. Prusiner. Scrapie prions. , 1989, Annual review of microbiology.